Diagnos Laboratorium Utama Tbk. vs Jakarta Setiabudi Internasional Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Jakarta Setiabudi Internasional Tbk trades at Rp1,395 (market cap 3.22T, 5K 24h volume). The key difference: Jakarta Setiabudi Internasional Tbk is far larger — about 10.4× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 5K). Which is the better fit depends on your goals.
| DGNS | JSPT | |
|---|---|---|
Market Cap | 310.75B | 3.22T |
Volume | 963.6K | 5K |
Lot | 9.64K | 50 |
Turnover | 217.67M | 6.89M |
Average Price | 225.89 | 1,378.9 |
Value | 217.67M | 6.89M |
Indicative Equilibrium Price | 226 | 1,390 |
Indicative Equilibrium Volume | 1K | 1K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Jakarta Setiabudi Internasional Tbk (the Company) was established in the Republic of Indonesia within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970 based on Notarial Deed No. 4 dated July 2, 1975 of Imas Fatimah, S.H., as amended by Notarial Deed No. 15 dated September 11, 1975 of the same notary. At the first time until 1996 this company was focusing in construction. Leasing and office building maintanance and apartment surrounding Kuningan area, Jakarta.
Read more on JSPT →